High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line <i>Helicobacter pylori</i> therapy: A randomized trial

Abstract

Fourteen-day high-dose dual therapy was both effective and safe for first-line treatment in a region of high prevalence antibiotic resistance. Adding bismuth only improved treatment effectiveness among smokers.